Schermafbeelding 2022 11 09 om 10.18.45 e1667989107505

A simple tool for a crazy task Normalization

Schermafbeelding 2022 11 09 om 10.18.22 e1667989084735

Eurobio scientific

Schermafbeelding 2022 11 09 om 10.17.44

Papers in 2021 Continue to Show Certain Glucose Meters Cause Serious Adverse Events Due to Interferants

Schermafbeelding 2022 11 09 om 10.17.26 e1667989049704

Shimadzu

Fits perfectly into your workflow

mesenchyml cells

Profiling of fatty sweet molecules on cell surfaces

Glycolipids, basically “fatty sweet” molecules, are a relatively unknown group of lipids. A new method developed by an Austrian team led by chemist Evelyn Rampler of the University of Vienna has now provided deeper insights into the functioning of certain glycolipids located on the surfaces of stem cells. The approach presented by the researchers from […]

shutterstock 1090252943

Biochemists find substance that makes cancer cells “suicidal”

The Peoples’ Friendship University of Russia (RUDN) biochemists have obtained a potential anti-cancer agent. The new substance pro-vokes cancer cells to commit “suicide” and at the same time does not affect healthy cells. The results are published in Molecules [1].

Maikel Rheinstadter team

Scientists test ‘smart’ red blood cells to deliver antibiotics that target specific bacteria

Physicists at McMaster University have identified a natural delivery system which can safely carry potent antibiotics throughout the body to selectively attack and kill bacteria by using red blood cells as a vehicle.

porvair vyon

Porvair’s new range of Vyon PTFE porous plastic materials ideal for temperature or chemical resistance applications

Porvair Sciences has developed a new range of Vyon PTFE porous plastic materials for applications where temperature or chemical resistance is important.

Q2

Q² Solutions unveils innovative self-collection safety lab panel in collaboration with Tasso

Q2 Solutions, a wholly owned subsidiary of IQVIA and a leading global clinical trial laboratory services organization, has launched the first self-collection safety lab panel for U.S. clinical trial participants by a leading global clinical trial laboratory.

Particle Works

Particle Works launches ALiS – an automated and high-throughput platform for LNP formulation screening

Particle Works continues to pave the way for particle perfection with the highly anticipated launch of its second revolutionary platform, the Automated Library Synthesis (ALiS) System. This innovative platform enables automation and high-throughput screening of lipid nanoparticle (LNP) formulations and mRNA candidates in early-stage drug development.